QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,174 signal articles · 353 in last 24h · 110,767 total before filter · latest 1h ago
353last 24h
2371last 7d
428● bullish (7d)
221● bearish (7d)
202publishers
AllMacro259Earnings1440M&A99Regulatory17Product17Analyst22
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Microsoft Stock Runs Into Resistance With Earnings Next; Is Microsoft A Sell Now?
Investor's Business Daily14d agobearish
Microsoft Stock Runs Into Resistance With Earnings Next; Is Microsoft A Sell Now?

Microsoft stock headed higher Tuesday, building on two straight advances as investors awaited the tech heavyweight's fourth-quarter earnings report due Wednesday. Is Microsoft stock a buy or sell now? Coming into Tuesday's session, the stock had risen more than 10% from its June lows and was running into its 50-day moving average.

📈 Earnings Snippet: Sherwin-Williams
The Wall Street Journal14d agoneutral
📈 Earnings Snippet: Sherwin-Williams

The paint maker's sales rose 7.5% to $6.79 billion in the recent quarter, ahead of the $6.6 billion that analysts polled by FactSet had expected. Shares climbed more than 8%, making Sherwin-Williams the top performer in the Dow industrials in what's poised to be the stock's biggest one-day increase in more than four years.

Uber autonomous vehicle outlook in focus for Q2 earnings
Proactive14d agoneutral
Uber autonomous vehicle outlook in focus for Q2 earnings

Uber Technologies Inc (NYSE:UBER, XETRA:UT8) is expected to report second quarter results that meet or modestly exceed Wall Street expectations, with analysts also anticipating investor attention to center on the company's autonomous vehicle strategy and outlook. Bank of America reiterated...

Kilroy Realty Q2 Earnings Call Highlights
MarketBeat14d agoneutral
Kilroy Realty Q2 Earnings Call Highlights

Kilroy Realty (NYSE:KRC) reported second-quarter funds from operations of $0.92 per diluted share and said leasing conditions continued to improve across its West Coast office and life science markets, supported by stronger tenant demand, reduced high-quality space availability and expanding renewal

Invesco Q2 Earnings Call Highlights
MarketBeat14d agoneutral
Invesco Q2 Earnings Call Highlights

Invesco (NYSE:IVZ) reported record second-quarter net long-term inflows and higher profitability as demand for ETFs, fixed income, separately managed accounts and private-market strategies helped push assets under management to $2.5 trillion. President and CEO Andrew Schlossberg said the firm gener

CocaCola Q2 Earnings Call Highlights
MarketBeat14d agoneutral
CocaCola Q2 Earnings Call Highlights

CocaCola (NYSE:KO) reported second-quarter results that management said reflected broad-based global momentum, with unit case volume rising 5%, organic revenue increasing 6%, and comparable earnings per share growing 11% to $0.97. Chief Executive Officer Henrique Braun said the quarter benefited fr

AMKR Q2 Deep Dive: Advanced Packaging Drives Growth Amid Guidance Caution
StockStory14d agoneutral
AMKR Q2 Deep Dive: Advanced Packaging Drives Growth Amid Guidance Caution

Semiconductor packaging and testing company Amkor Technology (NASDAQ:AMKR) announced better-than-expected revenue in Q2 CY2026, with sales up 25.6% year on year to $1.90 billion. On the other hand, next quarter’s revenue guidance of $2 billion was less impressive, coming in 4.1% below analysts’ estimates. Its non-GAAP profit of $0.70 per share was 45.4% above analysts’ consensus estimates.

Botox Maker Tops Buy Point, But Here Comes The Earnings Report
Investor's Business Daily14d agobullish
Botox Maker Tops Buy Point, But Here Comes The Earnings Report

AbbVie closed above the 230.47 buy point from a cup-with-handle base on June 23 and has climbed 15% from there. The previous day, the stock jumped more than 6% after AbbVie announced it agreed to acquire Apogee Therapeutics. The $10.9 billion deal would strengthen AbbVie's immunology pipeline.

Hilton Worldwide Q2 Earnings Call Highlights
MarketBeat14d agoneutral
Hilton Worldwide Q2 Earnings Call Highlights

Hilton Worldwide (NYSE:HLT) reported second-quarter results that exceeded its expectations, supported by stronger travel demand across business, group and leisure segments, while raising its full-year outlook for system-wide revenue per available room, or RevPAR. President and Chief Executive Offic